GitLab (GTLB) 10-Q 3 Jun 24 2025 Q1 Quarterly report Financial data

Cover

Cover - shares shares in Millions	3 Months Ended
	Apr. 30, 2024	May 16, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Apr. 30, 2024
Document Transition Report	false
Entity File Number	001-40895
Entity Registrant Name	GITLAB INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-1861035
Title of 12(b) Security	Class A common stock, par value $0.0000025per share
Trading Symbol	GTLB
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Address, Address Line One	251 Little Falls Drive
Entity Address, City or Town	Wilmington
Entity Address, State or Province	DE
Entity Address, Postal Zip Code	19808
Entity Central Index Key	0001653482
Current Fiscal Year End Date	--01-31
Current Fiscal Year Focus	2025
Current Fiscal Period Focus	Q1
Amendment Flag	false
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		132.7
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		26.2

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands		Apr. 30, 2024		Jan. 31, 2024
CURRENT ASSETS:
Cash and cash equivalents	[1]	$ 420,322		$ 287,996
Short-term investments	[1]	641,173		748,289
Accounts receivable, net of allowance for doubtful accounts of $582 and $673 as of April 30, 2024 and January 31, 2024, respectively	[1]	135,195		166,731
Deferred contract acquisition costs, current	[1]	31,034		32,300
Prepaid expenses and other current assets	[1]	35,319		45,601
Total current assets	[1]	1,263,043		1,280,917
Property and equipment, net	[1]	2,820		2,954
Operating lease right-of-use assets		543	[1]	405
Goodwill	[1]	16,070		8,145
Intangible assets, net	[1]	16,637		1,733
Deferred contract acquisition costs, non-current	[1]	17,738		19,317
Other non-current assets	[1]	4,776		4,390
TOTAL ASSETS	[1]	1,321,627		1,317,861
CURRENT LIABILITIES:
Accounts payable	[1]	3,230		1,738
Accrued expenses and other current liabilities	[1]	306,734		286,178
Accrued compensation and benefits	[1]	22,743		35,809
Deferred revenue, current	[1]	341,830		338,348
Total current liabilities	[1]	674,537		662,073
Deferred revenue, non-current	[1]	15,267		23,794
Other non-current liabilities	[1]	17,465		14,060
TOTAL LIABILITIES	[1]	707,269		699,927
Commitments and contingencies (Note 14)	[1]
STOCKHOLDERS’ EQUITY:
Preferred stock, $0.0000025 par value; 50,000 shares authorized as of April 30, 2024 and January 31, 2024; no shares issued and outstanding as of April 30, 2024 and January 31, 2024	[1]	0		0
Additional paid-in capital	[1]	1,768,947		1,718,661
Accumulated deficit	[1]	(1,204,466)		(1,149,822)
Accumulated other comprehensive income	[1]	3,360		2,335
Total GitLab stockholders’ equity	[1]	567,841		571,174
Noncontrolling interests	[1]	46,517		46,760
TOTAL STOCKHOLDERS’ EQUITY	[1]	614,358		617,934
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	[1]	1,321,627		1,317,861
Class A Common Stock
STOCKHOLDERS’ EQUITY:
Common stock, value, issued	[1]	0		0
Class B Common Stock
STOCKHOLDERS’ EQUITY:
Common stock, value, issued	[1]	$ 0		$ 0
[1] (1) As of April 30, 2024 and January 31, 2024, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $46.7 million and $47.6 million, respectively, and liabilities of $6.1 million and $6.1 million , respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the genera l credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands		Apr. 30, 2024	Jan. 31, 2024
Allowance for doubtful accounts		$ 582	$ 673
STOCKHOLDERS’ EQUITY:
Preferred stock, par value (in USD per share)		$ 0.0000025	$ 0.0000025
Preferred stock, shares authorized (in shares)		50,000,000	50,000,000
Preferred stock, shares issued (in shares)		0	0
Preferred stock, shares outstanding (in shares)		0	0
Assets of consolidated variable interest entity	[1]	$ 1,321,627	$ 1,317,861
Liabilities of consolidated variable interest entity	[1]	707,269	699,927
Variable Interest Entity, Primary Beneficiary
STOCKHOLDERS’ EQUITY:
Assets of consolidated variable interest entity		46,685	47,625
Liabilities of consolidated variable interest entity		$ 6,071	$ 6,080
Class A Common Stock
STOCKHOLDERS’ EQUITY:
Common stock, par value (in USD per share)		$ 0.0000025	$ 0.0000025
Common stock, shares authorized (in shares)		1,500,000,000	1,500,000,000
Common stock, shares issued (in shares)		132,670,000	114,670,000
Common stock, shares outstanding (in shares)		132,670,000	114,670,000
Class B Common Stock
STOCKHOLDERS’ EQUITY:
Common stock, par value (in USD per share)		$ 0.0000025	$ 0.0000025
Common stock, shares authorized (in shares)		250,000,000	250,000,000
Common stock, shares issued (in shares)		26,212,000	42,887,000
Common stock, shares outstanding (in shares)		26,212,000	42,887,000
[1] (1) As of April 30, 2024 and January 31, 2024, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $46.7 million and $47.6 million, respectively, and liabilities of $6.1 million and $6.1 million , respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the genera l credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Revenue	$ 169,187	$ 126,878
Cost of revenue	18,776	13,939
Gross profit	150,411	112,939
Operating expenses:
Sales and marketing	92,424	86,537
Research and development	54,140	50,387
General and administrative	57,487	34,248
Total operating expenses	204,051	171,172
Loss from operations	(53,640)	(58,233)
Interest income	12,030	7,315
Other income (expense), net	(567)	253
Loss before income taxes and loss from equity method investment	(42,177)	(50,665)
Loss from equity method investment, net of tax	0	(748)
Provision for income taxes	12,710	1,486
Net loss	(54,887)	(52,899)
Net loss attributable to noncontrolling interest	(243)	(430)
Net loss attributable to GitLab	$ (54,644)	$ (52,469)
Net loss per share attributable to GitLab Class A and Class B common stockholders, basic (in USD per share)	$ (0.35)	$ (0.35)
Net loss per share attributable to GitLab Class A and Class B common stockholders, diluted (in USD per share)	$ (0.35)	$ (0.35)
Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, basic (in shares)	158,157	151,692
Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, diluted (in shares)	158,157	151,692
Subscription—self-managed and SaaS
Revenue	$ 151,179	$ 111,191
Cost of revenue	13,839	10,891
License—self-managed and other
Revenue	18,008	15,687
Cost of revenue	$ 4,937	$ 3,048

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Statement of Comprehensive Income [Abstract]
Net loss	$ (54,887)	$ (52,899)
Foreign currency translation adjustments	2,632	(857)
Net change in unrealized gains (losses) on available-for-sale securities	(1,721)	1,497
Comprehensive loss including noncontrolling interest	(53,976)	(52,259)
Net loss attributable to noncontrolling interest	(243)	(430)
Foreign currency translation adjustments attributable to noncontrolling interest	(114)	(1,068)
Comprehensive loss attributable to noncontrolling interest	(357)	(1,498)
Comprehensive loss attributable to GitLab	$ (53,619)	$ (50,761)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total		Class A Common Stock	Common stock Class A Common Stock	Common stock Class B Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Noncontrolling Interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	$ 824,725			$ 0	$ 0	$ 1,497,373	$ (725,648)	$ (705)	$ 53,705
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2023				94,655,000	56,489,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of stock (in shares)				1,145,000	(1,145,000)
Issuance of common stock related to vested exercised stock options (in shares)					1,120,000
Issuance of common stock related to vested exercised stock options	7,613					7,613
Repurchases, net of early exercised stock options					(11,000)
Issuance of common stock related to RSUs vested (in shares)				359,000
Charitable donation of common stock (in shares)			80,742	81,000
Charitable donation of common stock	2,675		$ 2,700			2,675
Vesting of early exercised stock options	517					517
Stock-based compensation expense	32,330					34,804			(2,474)
Change in noncontrolling interest ownership						(379)			379
Other comprehensive income (loss)	640							1,708	(1,068)
Net loss	(52,899)						(52,469)		(430)
Stockholders' Equity, ending balance (in shares) at Apr. 30, 2023				96,240,000	56,453,000
Stockholders' Equity, ending balance at Apr. 30, 2023	815,601			$ 0	$ 0	1,542,603	(778,117)	1,003	50,112
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	815,601			0	0	1,542,603	(778,117)	1,003	50,112
Stockholders' Equity, beginning balance	$ 617,934	[1]		$ 0	$ 0	1,718,661	(1,149,822)	2,335	46,760
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2024				114,670,000	42,887,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of stock (in shares)				17,236,000	(17,236,000)
Issuance of common stock related to vested exercised stock options (in shares)	561,000				561,000
Issuance of common stock related to vested exercised stock options	$ 5,093					5,093
Issuance of common stock related to RSUs vested (in shares)				711,000
Charitable donation of common stock (in shares)			53,226	53,000
Charitable donation of common stock	2,957		$ 3,000			2,957
Vesting of early exercised stock options	98					98
Stock-based compensation expense	42,252					42,548			(296)
Change in noncontrolling interest ownership						(410)			410
Other comprehensive income (loss)	911							1,025	(114)
Net loss	(54,887)						(54,644)		(243)
Stockholders' Equity, ending balance (in shares) at Apr. 30, 2024				132,670,000	26,212,000
Stockholders' Equity, ending balance at Apr. 30, 2024	614,358	[1]		$ 0	$ 0	1,768,947	(1,204,466)	3,360	46,517
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	$ 614,358	[1]		$ 0	$ 0	$ 1,768,947	$ (1,204,466)	$ 3,360	$ 46,517
[1] (1) As of April 30, 2024 and January 31, 2024, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $46.7 million and $47.6 million, respectively, and liabilities of $6.1 million and $6.1 million , respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the genera l credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024		Apr. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss, including amounts attributable to noncontrolling interest	$ (54,887)		$ (52,899)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Stock-based compensation expense	42,252		32,330
Charitable donation of common stock	2,957		2,675
Amortization of intangible assets	1,087		579
Depreciation expense	937		1,092
Amortization of deferred contract acquisition costs	11,109		10,549
Loss from equity method investment	0		947
Net amortization of premiums or discounts on short-term investments	(4,900)		(3,596)
Unrealized foreign exchange loss (gain), net	545		(262)
Other non-cash expense (income), net	412		(59)
Changes in assets and liabilities:
Accounts receivable	31,072		4,840
Prepaid expenses and other current assets	10,354		(2,087)
Deferred contract acquisition costs	(8,540)		(8,497)
Other non-current assets	(419)		(302)
Accounts payable	1,336		(2,158)
Accrued expenses and other current liabilities	19,617		2,789
Accrued compensation and benefits	(13,152)		(5,121)
Deferred revenue	(4,448)		8,383
Other non-current liabilities	2,806		(164)
Net cash provided by (used in) operating activities	38,138		(10,961)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of short-term investments	(144,392)		(58,864)
Proceeds from maturities of short-term investments	254,687		83,500
Purchases of property and equipment	(700)		(256)
Payments for business combination, net of cash acquired	(20,210)		0
Net cash provided by investing activities	89,385		24,380
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from the issuance of common stock upon exercise of stock options, including early exercises, net of repurchases	5,093		7,513
Net cash provided by financing activities	5,093		7,513
Impact of foreign exchange on cash and cash equivalents	(290)		(401)
Net increase in cash and cash equivalents	132,326		20,531
Cash, cash equivalents, and restricted cash at beginning of period	287,996		297,902
Cash, cash equivalents, and restricted cash at end of period	420,322		318,433
Supplemental disclosure of cash flow information:
Cash paid for income taxes	1,011		1,066
Supplemental disclosure of non-cash investing and financing activities:
Vesting of early exercised stock options	98		517
Right-of-use assets obtained in exchange for new operating lease liabilities	284		0
Reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets to the amounts shown in the statements of cash flows above:
Cash and cash equivalents	420,322	[1]	315,933
Restricted cash, included in prepaid expenses and other current assets	0		2,500
Total cash, cash equivalents and restricted cash	420,322		318,433
Right-of-use assets obtained in exchange for new operating lease liabilities	$ 284		$ 0
[1] (1) As of April 30, 2024 and January 31, 2024, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $46.7 million and $47.6 million, respectively, and liabilities of $6.1 million and $6.1 million , respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the genera l credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Organization and Description of

Organization and Description of Business	3 Months Ended
	Apr. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	1. Organization and Description of Business GitLab Inc. (the “Company”) began as an open source project in 2011 and was incorporated in Delaware on September 12, 2014. The Company operates on an all-remote model. The Company is a technology company and its primary offering is “GitLab”, a complete DevSecOps platform delivered as a single application. GitLab is used by a wide range of organizations. The Company also provides related training and professional services. GitLab is offered on both self-managed and software-as-a-service ("SaaS") models. The principal markets for GitLab are currently located in the United States, Europe, and Asia Pacific. The Company is focused on accelerating innovation and broadening the distribution of its platform to companies across the world to help them become better software-led businesses.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	3 Months Ended
	Apr. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	2. Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP. Fiscal Year The Company's fiscal year ends on January 31. For example, references to fiscal year 2025 and 2024 refer to the fiscal year ending January 31, 2025 and the fiscal year ended January 31, 2024, respectively. Use of Estimates The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Such estimates include, but are not limited to, allocation of revenue to the license element in the Company's self-managed subscriptions, estimating the amortization period for capitalized costs to obtain a contract, allowance for doubtful accounts, stock-based compensa tion expense, fair value of contingent consideration, fair valuation of retained interest in an investee on loss of control, valuation allowance for deferred income taxes, reserves for unrecognized income tax benefits, valuation of acquired intangibles assets and impairment of goodwill and equity method investments. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates. Principles of Consolidation The condensed consolidated financial statements include 100% of the accounts of wholly owned and majority owned subsidiaries as well as a variable interest entity for which the Company is the primary beneficiary. The ownership interest of other investors is recorded as noncontrolling interest. All intercompany accounts and transactions have been eliminated in consolidation. Summary of Significant Accounting Policies There were no significant changes to the Company’s significant accounting policies disclosed in “Note 2” of the Company’s Annual Report on Form 10-K f or the fiscal year ended January 31, 2024 .

Revenues

Revenues	3 Months Ended
	Apr. 30, 2024
Revenue from Contract with Customer [Abstract]
Revenues	3. Revenues Disaggregation of Revenue The following table shows the components of revenues and their respective percentages of total revenue for the periods indicated (in thousands, except percentages): Three Months Ended April 30, 2024 2023 Subscription—self-managed and SaaS $ 151,179 89 % $ 111,191 88 % Subscription—self-managed 103,673 61 79,587 63 SaaS 47,506 28 31,604 25 License—self-managed and other $ 18,008 11 % $ 15,687 12 % License—self-managed 14,837 9 13,355 10 Professional services and other 3,171 2 2,332 2 Total revenue $ 169,187 100 % $ 126,878 100 % Total Revenue by Geographic Location The following table summarizes the Company’s total revenue by geographic location based on the region of the Company’s contracting entity, which may be different than the region of the customer (in thousands): Three Months Ended April 30, 2024 2023 United States $ 137,526 $ 102,962 Europe 27,652 20,957 Asia Pacific 4,009 2,959 Total revenue $ 169,187 $ 126,878 During the three months ended April 30, 2024 and 2023 , the United States accounted for 81% of total revenue. No other individual country exceeded 10% of total revenue for any of the periods presented. The Company operates its business as a single operating segment. Deferred Revenue During the three months ended April 30, 2024 and 2023, $125.3 million and $90.6 million, respectively, of revenue was recognized, which was included in the corresponding deferred revenue balance at the beginning of the periods presented. Remaining Performance Obligations As of April 30, 2024 and January 31, 2024, the aggregate amount of the transaction price allocated to bill ed and unbilled remaining performance obligations for which revenue has not yet been recognized was approximately $681.2 million and $673.8 million, respectively. As of April 30, 2024, the Company expects to recognize approximately 64% of the transaction price as product or services revenue over the next 12 months and 87% over the next 24 months. Concentration of Credit Risk and Significant Customers Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, short-term investments, and accounts receivable. At times, cash deposits may be in excess of insured limits. The Company believes that the financial institutions or corporations that hold its cash, cash equivalents, restricted cash, and short-term investments are financially sound and, accordingly, minimal credit risk exists with respect to these balances. The Company maintains allowances for potential credit losses on accounts receivable when deemed necessary. The Company uses various distribution channels. As of April 30, 2024 , two of these channel partners represented 10% and 14% of the accounts receivable balance, respectiv ely, while as of January 31, 2024, two of these channel partners represented 12% and 13% of the accounts receivable balance, respectively. There were no individual customers whose balance represented more than 10% of accounts receivable as of April 30, 2024 and January 31, 2024. There were no individual customers whose revenue represented more than 10% of total revenue during the three months ended April 30, 2024 and 2023.

Cash, Cash Equivalents and Shor

Cash, Cash Equivalents and Short-Term Investments	3 Months Ended
	Apr. 30, 2024
Cash and Cash Equivalents [Abstract]
Cash, Cash Equivalents and Short-Term Investments	4. Cash, Cash Equivalents and Short-Term Investments The following table summarizes the Company’s cash equivalents and short-term investments by category (in thousands): As of April 30, 2024 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Level 1: Cash equivalents (1) Money market funds $ 259,744 $ — $ — $ 259,744 Level 2: Cash equivalents (1) U.S. Treasury securities 57,887 — (3) 57,884 Commercial paper 12,916 — (3) 12,913 Total cash equivalents 330,547 — (6) 330,541 Short-term investments Commercial paper 27,592 2 (17) 27,577 Corporate debt securities 212,399 30 (692) 211,737 U.S. Agency securities 48,848 — (153) 48,695 U.S. Treasury securities 353,904 — (740) 353,164 Total short-term investments 642,743 32 (1,602) 641,173 Level 2 total 713,546 32 (1,608) 711,970 Total cash equivalents and short-term investments $ 973,290 $ 32 $ (1,608) $ 971,714 (1) Included in “cash and cash equivalents” in our condensed consolidated balance sheet as of April 30, 2024, in addition to cash of $89.8 million. As of January 31, 2024 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Level 1: Cash equivalents (1) Money market funds $ 187,175 $ — $ — $ 187,175 Level 2: Cash equivalents (1) U.S. Treasury securities 15,909 — (2) 15,907 Commercial paper 3,962 — (1) 3,961 Total cash equivalents 207,046 — (3) 207,043 Short-term investments Commercial paper 23,229 14 (1) 23,242 Corporate debt securities 231,219 740 (250) 231,709 U.S. Agency securities 56,324 29 (136) 56,217 U.S. Treasury securities 437,369 141 (389) 437,121 Total short-term investments 748,141 924 (776) 748,289 Level 2 total 768,012 924 (779) 768,157 Total cash equivalents and short-term investments $ 955,187 $ 924 $ (779) $ 955,332 (1) Included in “cash and cash equivalents” in our condensed consolidated balance sheet as of January 31, 2024, in addition to cash of $81.0 million. The fair value of the Company’s Level 1 financial instruments, such as money market funds which are traded in active markets, is based on quoted market prices for identical instruments. The fair value of the Company’s Level 2 financial instruments such as commercial paper, corporate debt and U.S. government securities are obtained from an independent pricing service, which may use inputs other than quoted prices that are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security that may not be actively traded. The Company’s marketable securities are held by custodians who obtain investment prices from a third-party pricing provider that incorporates standard inputs in various asset price models. The Company uses the specific-identification method to determine any realized gains or losses from the sale of the Company’s short-term investments classified as available-for-sale. For the three months ended April 30, 2024 and 2023 , the Company did not have any material realized gains or losses as a result of maturities or sales of short-term investments. During the three months ended April 30, 2024 and 2023, the Company recorded $12.0 million and $7.3 million of interest income on cash and cash equivalents and short-term investments, respectively, which includes $4.9 million and $3.6 million of net amortization of premiums or discounts on short-term investments during the three months ended April 30, 2024 and 2023, respectively. The following table summarizes unrealized losses on the Company’s cash equivalents and short-term investments aggregated by category and the length of time such aggregated investments have been in a continuous unrealized loss position as of the periods presented (in thousands): Less Than 12 Months 12 Months or Greater Total Carrying Value Gross Unrealized Losses Carrying Value Gross Unrealized Losses Fair Value Gross Unrealized Losses April 30, 2024 U.S. Agency securities $ 36,247 $ (113) $ 9,448 $ (40) $ 45,695 $ (153) Commercial paper 37,421 (20) — — 37,421 (20) Corporate debt securities 168,986 (675) 13,195 (17) 182,181 (692) U.S. Treasury securities 392,924 (704) 18,124 (39) 411,048 (743) Total cash equivalents and short-term investments $ 635,578 $ (1,512) $ 40,767 $ (96) $ 676,345 $ (1,608) Less Than 12 Months 12 Months or Greater Total Carrying Value Gross Unrealized Losses Carrying Value Gross Unrealized Losses Fair Value Gross Unrealized Losses January 31, 2024 U.S. Agency securities $ 35,979 $ (53) $ 11,386 $ (83) $ 47,365 $ (136) Commercial paper 15,462 (2) — — 15,462 (2) Corporate debt securities 85,998 (192) 15,485 (58) 101,483 (250) U.S. Treasury securities 139,567 (192) 41,193 (199) 180,760 (391) Total cash equivalents and short-term investments $ 277,006 $ (439) $ 68,064 $ (340) $ 345,070 $ (779) The following table classifies the Company’s short-term investments by contractual maturities (in thousands): April 30, 2024 January 31, 2024 Amortized cost Fair Value Amortized cost Fair Value Due within 1 year $ 500,465 $ 499,318 $ 619,286 $ 618,765 Due between 1 year to 2 years 142,278 141,855 128,855 129,524 Total $ 642,743 $ 641,173 $ 748,141 $ 748,289 All available-for-sale securities have been classified as current, based on management’s ability to use the funds in current operations. Liabilities are measured at fair value on a recurring basis. The Company has contingent cash consideration from business acquisitions which is determined based upon the satisfaction of certain defined operational milestones and remeasured at fair value at each reporting period through earnings. As the fair value is based on unobservable inputs, the liability is included in Level 3 of the fair value measurement hierarchy. The Company reassessed the fair value of outstanding operational milestones and there was no change d uring the three months ended April 30, 2024 and 2023. The Company h ad $3.7 million and $3.6 million of Level 3 contingent consideration as of April 30, 2024 and January 31, 2024, respec tively. Interest accretion expense on contingent cash consideration wa s immaterial fo r th e three months ended April 30, 2024 and 2023.

Supplemental Financial Statemen

Supplemental Financial Statement Information	3 Months Ended
	Apr. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Supplemental Financial Statement Information	5. Supplemental Financial Statement Information Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): April 30, 2024 January 31, 2024 Income tax liability related to BAPA (1) $ 265,254 $ 258,675 Accrued expenses 21,015 11,499 ESPP employee contributions 6,912 2,827 Acquisition related liabilities (2) 3,766 3,608 Income taxes payable 3,380 2,212 Customer refunds payable 3,335 3,019 Indirect taxes payable 2,701 3,928 Operating lease liabilities, current 371 410 Total accrued expenses and other current liabilities $ 306,734 $ 286,178 (1) Refer to “Note 12. Income Taxes” for a discussion on the unrecognized tax benefits related to the BAPA. (2) $0.1 million relates to Oxeye acquisition founder holdback (see Note 6. Business Combination ) and $3.7 million relates to Opstrace acquisition. Other Inc ome (Expense), Net Other income (expense), net consisted of the following (in thousands): Three Months Ended April 30, 2024 2023 Foreign exchange gains (losses), net $ (637) $ 274 Other income (expense), net 70 (21) Total other income (expense), net $ (567) $ 253

Business Combination

Business Combination	3 Months Ended
	Apr. 30, 2024
Business Combination and Asset Acquisition [Abstract]
Business Combination	6. Business Combination On March 20, 2024 (the “Acquisition Date”), the Company completed the acquisition of Oxeye Security Limited (“Oxeye”), a cloud-native application security and risk management solution company based in Israel. The Company believes this acquisition will allow the Company to strengthen its product offerings. The transaction was accounted for as a business combination. The Acquisition Date fair value of the consideration transferred consisted of the following (in thousands): Closing cash consideration $ 16,737 Cash held in escrow 3,593 Total consideration $ 20,330 Total consideration includes $3.6 million deposited in an escrow account as partial security for post-closing indemnification claims made within 15 months of the Acquisition Date. As the Company is not the legal owner of the escrow account, it is not recorded on the condensed consolidated balance sheet as of April 30, 2024. As part of the acquisition, there was also a holdback in the amount of $3.2 million (the “holdback”). The holdback will be paid to the two co-founders (the “founder holdback”) in three equal tranches of 33.3%. The first such payment will be paid if certain milestones are achieved on or before the first anniversary of the closing date, provided such founder is employed by the Company on the first anniversary. The second and third tranches will be paid provided such founder is employed by the Company on the second and third anniversaries of the closing dates, respectively. As the founder holdback arrangement represents compensation for post-combination services, the Company has excluded the entire $3.2 million from the purchase price to be allocated, and will recognize the amount as expense over the period of services rendered after factoring in the likelihood of achieving the milestones. During the three months ended April 30, 2024, $0.1 million of the founder holdback was expensed by the Company in general and administrative expenses in its condensed consolidated statement of operations. Acquisition related transaction costs were $1.3 million for the three months ended April 30, 2024 and were expensed by the Company in general and administrative expenses in its condensed consolidated statement of operations. The Company recorded the assets acquired and liabilities assumed at their estimated fair values, with the difference between the fair value of the net assets acquired and the purchase consideration reflected in goodwill. The total purchase price of $20.3 million was allocated using information available to the Company at the time of acquisition. The Company may continue to adjust the preliminary purchase price allocation after obtaining more information regarding asset valuations, liabilities assumed, tax-related items and revisions of preliminary estimates. During the three months ended April 30, 2024, there were no measurement period adjustments identified and recorded. The following table reflects the fair values of assets acquired and liabilities assumed (in thousands): Cash and cash equivalents $ 120 Developed technology 16,276 Goodwill 8,055 Prepaid expenses and other current assets 121 Accrued expenses and payroll (3,582) Deferred tax liability (660) Net assets acquired $ 20,330 As of March 20, 2024, developed technology of the acquired business had an estimated useful life of three years. The fair value of the developed technology intangible asset was estimated using the replacement cost method, which utilizes assumptions for the cost to replace it, such as time and resources required, as well as a theoretical profit margin and opportunity costs. The goodwill is primarily attributed to the synergies expected to be realized following the acquisition. The goodwill is not deductible for Israeli income tax purposes. Results of operations of the business acquired have been included in the Company’s condensed consolidated financial statements subsequent to the date of acquisition. The revenue and net income (loss) earned by the business acquired following the acquisition are not material to the Company’s condensed consolidated results of operations; and accordingly, pro forma financial statements have not been presented.

Goodwill and Intangible Assets,

Goodwill and Intangible Assets, Net	3 Months Ended
	Apr. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets, Net	7. Goodwill and Intangible Assets, Net Goodwill The carrying amount of goodwill was as follows (in thousands): Carrying Amount Balance as of January 31, 2024 $ 8,145 Acquisition of Oxeye 8,055 Foreign currency translation adjustments (130) Balance as of April 30, 2024 $ 16,070 There was no goodwill impairment for any periods presented. Intangible Assets Intangible assets, net consisted of the following (in thousands): April 30, 2024 (1) Gross Carrying Amount Accumulated Amortization Net Book Value Weighted average remaining amortization period (years) Developed technology from business combination $ 22,192 $ (5,555) $ 16,637 2.5 Developed technology from asset acquisitions 906 (906) — 0.0 Total $ 23,098 $ (6,461) $ 16,637 January 31, 2024 Gross Carrying Amount Accumulated Amortization Net Book Value Weighted average remaining amortization period (years) Developed technology from business combination $ 6,200 $ (4,467) $ 1,733 0.8 Developed technology from asset acquisitions (1) 914 (914) — 0.0 Total $ 7,114 $ (5,381) $ 1,733 (1) The amounts in the tables above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying intangibles. Amortization expense w a s $1.1 million and $0.6 million for t h e three months ended April 30, 2024 and 2023, respectively. As of April 30, 2024, future a mortization expense related to the intangibles assets is expected to be as follows (in thousands): Fiscal Years 2025 $ 5,221 2026 5,330 2027 5,330 2028 756 Total future amortization $ 16,637

Team Member Benefit Plans

Team Member Benefit Plans	3 Months Ended
	Apr. 30, 2024
Retirement Benefits [Abstract]
Team Member Benefit Plans	8. Team Member Benefit Plans The Company contributes to defined c ontribution plans in a number of countries including a 401(k) savings plan for U.S. based team members and defined contribution arrangements in the United Kingdom, Australia, New Zealand and select other countries based on the legislative and tax requirements of the respective countries. Total contributions to these plans were $1.8 million and $1.7 million for t he three months ended April 30, 2024 and 2023 , respectively.

Equity

Equity	3 Months Ended
	Apr. 30, 2024
Equity [Abstract]
Equity	9. Equity Common Stock The Company had shares of common stock reserved for future issuance as follows (in thousands): April 30, 2024 January 31, 2024 Class A and Class B common stock Options issued and outstanding 7,880 8,503 Shares available for issuance under Equity Incentive Plans 30,067 24,868 RSUs and PSUs issued and outstanding 12,960 10,930 Shares reserved for issuance to charitable organizations 1,351 1,404 ESPP 6,974 5,398 Total 59,232 51,103 Equity Incentive Plans In September 2021, the Company adopted the 2021 Equity Incentive Plan (the “2021 Plan”) as a successor of the Company’s 2015 Equity Incentive Plan (together the “Plans”). Effective February 1, 2024 , the number of shares available under the 2021 Plan was automatically increased by 7,877,919 shar es pursuant to the terms of the 2021 Plan. The awards available for grant under the above Plans for the pe riods presented were as follows (in thousands): April 30, 2024 January 31, 2024 Available at beginning of period 24,868 21,483 Awards authorized 7,878 7,557 RSUs and PSUs granted (3,159) (6,258) RSUs and PSUs canceled and forfeited 418 1,292 Options canceled and forfeited 62 777 Options repurchased — 17 Available at end of period 30,067 24,868 In the event that shares previously issued u nder the above Plans are reacquire d by the Company, such shares shall be added to the number of shares then available for issuance under the 2021 Plan. In the event that an outstanding stock option for any reason expires or is canceled, the shares allocable to the unexercised portion of su ch stock option will be added to the number of shares then available for issuance under the 2021 Plan. Both Plans allow the grantees to early exercise stock options. Stock Options, RSUs and PSUs The following table summarizes options activity under the Plans, and related information: Number of Stock Options Outstanding (in thousands) Weighted Average Exercise Price Weighted Average Remaining Years Aggregate Intrinsic value (in millions) Balances at January 31, 2024 8,503 $ 13.03 5.85 $ 499.2 Options granted — — — Options exercised (561) 9.08 — Options canceled (6) 10.11 — Options forfeited (56) 18.79 — Balances at April 30, 2024 7,880 $ 13.27 5.63 $ 312.6 Options vested at April 30, 2024 6,213 $ 11.98 5.37 $ 251.6 Options vested and expected to vest at April 30, 2024 7,880 $ 13.27 5.63 $ 312.6 During the three months ended April 30, 2024 and 2023, the Company recorded $3.5 million and $4.8 million stock-based compensation expenses related to options, respectively. As of April 30, 2024, approximately $17.6 million of total unrecognized compensation cost was related to stock options granted, that is expected to be recognized over a weighted-average period of 1.4 years. The expected stock compensation expense remaining to be recognized reflects only outstanding stock awards as of the periods presented, and assumes no forfeitures. The following table summarizes the Company’s RSU activity: Number of Shares (in thousands) (1) Weighted- Balances at January 31, 2024 7,701 $ 47.20 Granted 3,159 56.18 Vested (711) 47.77 Canceled/forfeited (418) 50.02 Balances at April 30, 2024 9,731 $ 49.93 (1) The table above does not include 3 million RSUs granted to the Company’s founder and the Chief Executive Officer (“CEO”) described below. These RSUs are grants of shares of the Company’s common stock, the vesting of which is based on the requisite service requirement. Generally, the Company’s RSUs are subject to forfeiture and are expected to vest over two As of April 30, 2024, approximately $468.5 million of total unrecognized compensation cost was related to RSUs granted to team members other than the CEO, that is expected to be recognized over a weighted-average period of 3.1 years. The expected stock compensation expense remaining to be recognized reflects only outstanding stock awards as of the periods presented, and assumes no forfeitures. In June 2022, the Company granted 0.4 million PSUs to senior members of its management team subject to revenue performance condition and service conditions. The number of awards granted represents 100% of the target goal; under the terms of the awards, the recipient may earn between 0% and 200% of the original grant. The performance c ondition is set to be achieved in fiscal year 2025 and the service condition in calendar year 2025. The Company recorded $0.6 million and $0.4 million of stock-based compensation expense related to PSUs during the three months ended April 30, 2024 and 2023 , respectively. As of April 30, 2024, unrecognized stock-based compensation expense related to these PSUs was $2.3 million to be recognized over a period of 1.6 years. CEO Performance Award In May 2021, the Company granted 3 million RSUs tied to its Class B common stock to Sytse Sijbrandij, the Company’s co-founder and CEO, with an estimated aggregate grant date fair value of $8.8 million. During the three months ended April 30, 2024 and 2023, the Company recorded $0.4 million of stock-based compensation expense related to the CEO RSUs. As measured from the grant date, the derived service period of the respective tranches ranges from 2 to 7 years. As of April 30, 2024, unrecognized stock-based compensation expense related to these RSUs was $3.9 million which will be recognized over 4.6 years. 2021 Employee Stock Purchase Plan (“ESPP”) In September 2021, the Company’s board of directors and its stockholders approved the ESPP and participation of eligible team members. Effective as of February 1, 2024, the number of shares available under the ESPP was automatically increased by 1,575,583 shares pursuant to the terms of the 2021 ESPP. The Company rec orded $2.6 million and $4.5 million of stock-based compensation expense related to the ESPP during the three months ended April 30, 2024 and 2023, respectively. As of April 30, 2024, approximately $10.1 million of total unrecognized compensation cost was related to the ESPP that is expected to be recognized over 1.6 years. Stock-Based Compensation Expense The Company recognized stock-based compensation expense as follows (in thousands): Three Months Ended April 30, 2024 2023 Cost of revenue $ 1,855 $ 1,414 Sales and marketing 17,397 13,764 Research and development 12,336 11,702 General and administrative 10,664 5,450 Total stock-based compensation expense (1) $ 42,252 $ 32,330 (1) The table above includes stock-based compensation of JiHu. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion. The corporate income tax benefit recognized in the condensed consolidated statements of operations for stock-based compensation expense was zero and $2.8 million for the three months ended April 30, 2024 and 2023 , respectively. Charitable Donation of Common Stock In September 2021, the Company’s board of directors approved the reservation of up to 1,635,545 shares of Class A common stock for issuance to charitable organizations. In March 2024 and 2023, the Company’s board of directors approved the donation of $11.8 million and $10.7 million aggregate principal amount of shares of Class A common stock to the GitLab Foundation (the “Foundation”), a California nonprofit public benefit corporation, respectively. The Foundation is also a related party as certain of the Company’s officers serve as directors of the Foundation. These donations shall occur in four equal quarterly distributions. During the three months ended April 30, 2024 and 2023, the Company donated 53,226 shares and 80,742 shares of Class A common stock at fair value to the Foundation, respectively. The fair value of the common stock was determined based on the quoted market price on the grant date. The donation expense of $3.0 million and $2.7 million was recorded in general and administrative expense in the condensed consolidated statements of operations for the three months ended April 30, 2024 and 2023, respectively.

Restructuring and Other Related

Restructuring and Other Related Charges	3 Months Ended
	Apr. 30, 2024
Restructuring and Related Activities [Abstract]
Restructuring and Other Related Charges	10. Restructuring and Other Related Charges In February 2024, the Company restructured certain departments to better align functions and recognized total restructuring charges of approximately $1.0 million during the three months ended April 30, 2024. In February 2023, the Company reduced its total global headcount by approximately 7% . As a result, the Company recognized total restructuring charges of approximately $9.0 million during the three months ended April 30, 2023, which consisted primarily of one-time severance and other termination benefit costs of $7.7 million, as well as accelerated stock-based compensation of $1.3 million. The Company recognized severance and other termination benefit costs as follows (in thousands): Three Months Ended April 30, 2024 2023 Cost of revenue $ — $ 417 Research and development — 2,059 Sales and marketing 730 3,559 General and administrative 276 1,618 Total (1) $ 1,006 $ 7,653 (1) Excludes stock-based compensation of zero and $1.3 million for the three months ended April 30, 2024 and 2023, respectively. The changes in liabilities resulting from the restructuring charges and related accruals were as follows (in thousands) : Balance as of January 31, 2024 $ 188 Charges 1,006 Cash payments (1,176) Balance as of April 30, 2024 (1) $ 18 (1) Balance is included in accrued compensation and benefits on the condensed consolidated balance sheet as of April 30, 2024.

Joint Venture and Equity Method

Joint Venture and Equity Method Investment	3 Months Ended
	Apr. 30, 2024
Noncontrolling Interest [Abstract]
Joint Venture and Equity Method Investment	11. Joint Venture and Equity Method Investment Joint Venture In February 2021, the Company along with Sequoia CBC Junyuan (Hubei) Equity Investment Partnership (Limited Partnership) and Suzhou Gaocheng Xinjian Equity Investment Fund Partnership (Limited Partnership) executed an investment agreement (the “Investment Agreement”) to establish GitLab Information Technology (Hubei) Co., LTD (“JiHu”), a legal entity in the People’s Republic of China. The Company accounted for JiHu as a variable interest entity and consolidated the entity in accordance with ASC Topic 810, Consolidation. As of April 30, 2024, the Company retains control over JiHu with its equity stake at approxima tely 54%. JiHu maintains an employee stock option plan (“JiHu ESOP”) for its employees. As a result of forfeitures triggered by the departure of key executives during the three months ended April 30, 2024 and 2023 , t he Company reversed stock-based compensation previously recorded which resulted in a $0.3 million gain and $2.5 million gain, respectively. As of April 30, 2024, approximately $1.2 million of total unrecognized compensation cost was related to the JiHu ESOP that is expected to be recognized over 3.6 years. Operating Leases JiHu entered into a new lease in March 2024 and has various non-cancelable long-term operating leases maturing by June 30, 2026 with total lease payments of $0.5 million and a total present value of lease liabilities of $0.5 million. In addition, there is one short-term lease for which the associated lease expense was immaterial during the three months ended April 30, 2024 and 2023. The Company recognized $0.2 million of operating lease expense during the three months ended April 30, 2024 and 2023. The table below presents supplemental information related to operating leases for the three months ended April 30, 2024 (in thousands, except weighted-average information): Weighted-average remaining lease term (in years) 0.88 Weighted-average discount rate 3.6 % Right-of-use assets obtained in exchange for new operating lease liabilities $ 284 Cash paid for amounts included in the measurement of lease liabilities $ 195 Selected Financial Information Selected financial information of JiHu, post intercompany eliminations, is as follows (in thousands): Three Months Ended April 30, 2024 2023 Revenue $ 1,646 $ 1,464 Cost of revenue 484 491 Gross profit 1,162 973 Operating expenses: Sales and marketing 1,635 2,084 Research and development (211) 1,956 General and administrative 838 (1,444) Total operating expenses 2,262 2,596 Loss from operations (1,100) (1,623) Interest income 227 315 Other income, net 347 269 Net loss before income taxes (526) (1,039) Net loss $ (526) $ (1,039) Net loss attributable to noncontrolling interest $ (243) $ (430) April 30, 2024 January 31, 2024 Cash and cash equivalents $ 41,901 $ 43,896 Property and equipment, net 357 489 Operating lease right-of-use assets 543 405 Other assets 3,884 2,835 Total assets $ 46,685 $ 47,625 Total liabilities $ 6,071 $ 6,080 Equity Method Investment In April 2021, the Company reorganized Meltano Inc. (“Meltano”), now operating as Arch Data, Inc. (“Arch”), which started as an internal project within the Company in July 2018, into a separate legal entity. The Company recorded an impairment charge of $8.9 million in other income (expense), net in the condensed consolidated statement of operations during the year ended January 31, 2024 which reduced the equity method investment value to zero a s of January 31, 2024 . During the three months ended April 30, 2024 and 2023 , the Company recorded a loss from equity method investment of zero and $0.7 million, net of tax on the condensed consolidated statements of operations, respectively.

Income Taxes

Income Taxes	3 Months Ended
	Apr. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	12. Income Taxes For the three months ended April 30, 2024, the Company recorded income tax expense of $12.7 million on pretax loss of $42.2 million. The income tax expense for the three months ended April 30, 2024 was primarily related to an increase in tax expense for unrecognized tax benefits and the Company's foreign and domestic operations. For the three months ended April 30, 2023 , the Company recorded income tax expense of $1.5 million on pretax loss of $50.7 million . The income tax expense for the three months ended April 30, 2023 was primarily related to the Company's foreign and domestic operations. The Company's provision for income taxes is based on its worldwide estimated annualized effective tax rate, except for jurisdictions for which a loss is expected for the year and no benefit can be realized for those losses, jurisdictions for which forecasted pre-tax income or loss cannot be estimated, and the tax effect of discrete items occurring during the period. The tax provision for jurisdictions for which a forecast cannot be estimated is based on actual taxes and tax reserves for the quarter. Under the provisions of ASC 740, Income Taxes , the determination of the Company’s ability to recognize its deferred tax asset requires an assessment of both negative and positive evidence when determining the Company’s ability to recognize its deferred tax assets. As in prior years, the Company maintained that it was not more likely than not that the Company could recognize deferred tax assets in certain jurisdictions. The evidence evaluated by the Company included operating results during the most recent three-year period and future projections. More weight was given to historical results than to expectations of future profitability, which are inherently uncertain. Certain entities’ net losses in recent periods represented sufficient negative evidence to require a valuation allowance against its net deferred tax assets. This valuation allowance will be evaluated periodically and could be reversed partially or totally if business results have sufficiently improved to support realization of deferred tax assets. As of April 30, 2024, unrecognized tax benefits were $398.3 million, of which $210.3 million would affect the effective tax rate if recognized. The Company has classified approximately $209.7 million of unrecognized tax benefit as current tax liability due to anticipated timing of the settlement of the bilateral advance pricing agreement (“BAPA”) with the U.S. Internal Revenue Service (“IRS”) and Dutch Tax Authority (“DTA”) and their associated payments, which are expected to be made within the next 12 months. The Company is unable to reasonably estimate the timing of remaining long-term payments or the amount by which the liability will increase or decrease. It is the Company’s policy to classify accrued interest and penalties related to unrecognized tax benefits in provision for income taxes. Accrued interest and penalties were $56.7 million as of April 30, 2024 and $52.1 million as of January 2024, respectively. The Company has been in BAPA negotiations between the IRS and the DTA relating to the Company’s transfer pricing arrangements between the United States and the Netherlands. In the year ended January 31, 2024, the Company for the first time discussed with the IRS and DTA a framework to finalize its transfer pricing arrangements for the proposed BAPA period consisting of tax years ending December 31, 2018 through January 31, 2027. The proposed agreements between the Company, the IRS and the DTA are not yet final; in anticipation of the agreements, $254.9 million of net tax liability was recorded in the year ended January 31, 2024, and an additional $8.7 million of net tax liability was recorded for the three months ended April 30, 2024. These amounts represent the unrecognized tax benefit relating to the BAPA. The unrecognized tax benefit represents the Company’s best estimate of the tax liability associated with the proposed agreements and their related effects. As of April 30, 2024, the Company’s U.S. federal 2018 through 2022 tax years were open and subject to potential examination in one or more jurisdictions. In addition, in the United States, any net operating losses or credits that were generated in prior years but not yet fully utilized in a year that is closed under the statute of limitations may also be subject to examination. The Company is currently under examination in the Netherlands for the tax years ended December 31, 2015 and 2016. The Company expects negotiations to continue to the middle of fiscal year 2025. The Company believes that it has adequately reserved for the outcome of this audit. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of its provision for income taxes. The Company continues to monitor the progress of ongoing discussions with tax authorities and the effect, if any, of the expected expiration of the statute of limitations in various taxing jurisdictions.

Net Loss per Share

Net Loss per Share	3 Months Ended
	Apr. 30, 2024
Earnings Per Share [Abstract]
Net Loss per Share	13. Net Loss per Share The following table sets forth basic and diluted loss per share for each of the periods presented (in thousands, except per share data): Three Months Ended April 30, 2024 2023 Numerator: Net loss attributable to GitLab $ (54,644) $ (52,469) Denominator: Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted 158,157 151,692 Net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted $ (0.35) $ (0.35) Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods as the inclusion of all potential common shares outstanding would have been anti-dilutive. Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in thousands): As of April 30, 2024 January 31, 2024 Shares subject to outstanding common stock options 7,880 8,503 Unvested restricted stock in connection with business combination 2 3 Unvested early exercised stock options 17 22 Unvested RSUs and PSUs 12,960 10,930 Shares subject to the ESPP 155 63 Total 21,014 19,521

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Apr. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	14. Commitments and Contingencies Contractual Obligations and Commitments The Company’s purchase oblig ations of $136.8 million as of April 30, 2024 , represent third-party non-cancelable hosting infrastructure agreements, subscription arrangements and other commitments used in the ordinary course of business to meet operational requirements. Loss Contingencies In accordance with ASC 450, Loss Contingencies, the Company accrues for contingencies when losses become probable and reasonably estimable. Accordingly, the Company has recorded an estimated liability related to certain labor matters regarding its use o f contractors in certain foreign countries. As of April 30, 2024 and January 31, 2024, the estimated liability relating to these matters was $2.1 million and $2.2 million recorded in other non-current liabilities on the condensed consolidated balance sheets, respectively. Warranties and Indemnifications The Company enters into service level agreements with customers which warrant defined levels of uptime and support response times and permit those customers to receive credits for prepaid amounts in the event that those performance and response levels are not met. To date, the Company has not experienced any significant failures to meet defined levels of performance and response. In connection with the service level agreements, the Company has not incurred any significant costs and has not accrued any liabilities in the condensed consolidated financial statements. In the ordinary course of business, the Company enters into contractual arrangements under which the Company agrees to provide indemnification of varying scope and terms to business partners and other parties with respect to certain matters, including, but not limited to, losses arising out of the breach of such agreements, intellectual property infringement claims made by third parties, and other liabilities relating to or arising from the Company’s platform or the Company’s acts or omissions. In these circumstances, payment may be conditional on the other party making a claim pursuant to the procedures specified in the particular contract. Further, the Company’s obligations under these agreements may be limited in terms of time and/or amount, and in some instances, the Company may have recourse against third parties for certain payments. In addition, the Company has agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines, and settlement amounts incurred by any of these persons in any action or proceeding to which any of those persons is, or is threatened to be, made a party by reason of the person’s service as a director or officer, including any action by the Company, arising out of that person’s services as the Company’s director or officer or that person’s services provided to any other company or enterprise at the Company’s request. The Company maintains director and officer insurance coverage that may enable the Company to recover a portion of any future amounts paid. Legal Proceedings The Company is, and from time to time, may become involved in legal proceedings or be subject to claims arising in the ordinary course of its business. The Company is not presently a party to any legal proceedings that in the opinion of management, if determined adversely to the Company, would individually or taken together have a material adverse effect on its business, financial condition or operating results.

Subsequent Event

Subsequent Event	3 Months Ended
	Apr. 30, 2024
Subsequent Events [Abstract]
Subsequent Event	15. Subsequent Event On May 23, 2024, the Company completed its acquisition of certain assets, primarily software intellectual property, of Rezilion Inc. and its subsidiary, Rezilion Ltd. (collectively, “Rezilion”) for approximately $7.3 million in cash, subject primarily to a one-time payment to the Israel Innovation Authority and settlement of a bank borrowing, and the assumption of select liabilities. Select employees of Rezilion have also joined the Company. Rezilion has developed software security solutions and this transaction will allow the Company to strengthen its product offerings.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (54,644)	$ (52,469)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Apr. 30, 2024 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Merline Saintil [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	Merline Saintil 10b5-1 Plan On March 27, 2024, Merline Saintil, a member of the Company’s board of directors, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “Saintil Rule 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company’s Class A common stock. The Saintil Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Saintil Rule 10b5-1 Plan provides for the potential sale of shares of the Company’s Class A common stock, including upon the vesting and settlement of restricted stock units, so long as the market price of the Company’s Class A common stock is higher than certain minimum threshold prices specified in the Saintil Rule 10b5-1 Plan, between June 26, 2024 and March 31, 2025. The aggregate number of shares of Class A common stock that will be available for sale under the Saintil Rule 10b5-1 Plan is not yet determinable because the shares available will be net of shares sold to satisfy tax withholding obligations that arise in connection with the vesting and settlement of such restricted stock unit awards. As such, for purposes of this disclosure, the aggregate number of shares of Class A common stock available for sale is approximately 2,511, which reflects the aggregate maximum number of shares underlying Ms. Saintil’s restricted stock units which may be sold, without excluding the shares that will be sold to satisfy the tax withholding obligations. The Saintil Rule 10b5-1 Plan includes a representation from Ms. Saintil to the broker administering the plan that she was not in possession of any material nonpublic information regarding the Company or the securities subject to the Saintil Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the Saintil Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the Saintil Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Ms. Saintil was unaware, or with respect to any material nonpublic information acquired by Ms. Saintil or the Company after the date of the representation.
Name	Merline Saintil
Title	member of the Company’s board of directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	March 27, 2024
Arrangement Duration	278 days
Aggregate Available	2,511
Karen Blasing [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	Karen Blasing 10b5-1 Plan On March 26, 2024, Karen Blasing, a member of the Company’s board of directors, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “Blasing Rule 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company’s Class A common stock. The Blasing Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Blasing Rule 10b5-1 Plan provides for the potential sale of up to 76,430 shares of the Company’s Class A common stock so long as in each case the market price of the Company’s Class A common stock is higher than certain minimum threshold prices specified in the Blasing Rule 10b5-1 Plan, between June 25, 2024 and March 31, 2026. The aggregate number of shares of Class A common stock that will be available for sale under the Blasing Rule 10b5-1 Plan is not yet determinable because the shares available will be net of shares sold to satisfy tax withholding obligations that arise in connection with the settlement of such already vested restricted stock unit awards and exercise and settlement of such stock options. As such, for purposes of this disclosure, the aggregate number of shares of Class A common stock available for sale is approximately 76,430, which reflects the aggregate maximum number of shares underlying Ms. Blasing’s restricted stock units and stock options which may be sold, without excluding the shares that will be sold to satisfy the tax withholding obligations. The Blasing Rule 10b5-1 Plan includes a representation from Ms. Blasing to the broker administering the plan that she was not in possession of any material nonpublic information regarding the Company or the securities subject to the Blasing Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the Blasing Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the Blasing Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Ms. Blasing was unaware, or with respect to any material nonpublic information acquired by Ms. Blasing or the Company after the date of the representation.
Name	Karen Blasing
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	March 26, 2024
Arrangement Duration	644 days
Aggregate Available	76,430
Erin Mannix [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	Erin Mannix New 10b5-1 Plan On March 28, 2024, Erin Mannix, the Company’s Chief Accounting Officer, entered into a new pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “New Mannix Rule 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company’s Class A common stock. The New Mannix Rule 10b5-1 Plan will take effect on July 1, 2024 and on June 28, 2024 Ms. Mannix’s existing Rule 10b5-1 Plan will terminate according to its terms. The New Mannix Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The New Mannix Rule 10b5-1 Plan provides for the potential sale of shares of the Company’s Class A common stock, including upon the vesting and settlement of restricted stock units, so long as the market price of the Company’s Class A common stock is higher than certain minimum threshold prices specified in the New Mannix Rule 10b5-1 Plan, between July 1, 2024 and March 24, 2025. The aggregate number of shares of Class A common stock that will be available for sale under the New Mannix Rule 10b5-1 Plan is not yet determinable because the shares available will be net of shares sold to satisfy tax withholding obligations that arise in connection with the vesting and settlement of such restricted stock unit awards. As such, for purposes of this disclosure, the aggregate number of shares of Class A common stock available for sale is approximately 17,797, which reflects the aggregate maximum number of shares underlying Ms. Mannix’s restricted stock units which may be sold, without excluding the shares that will be sold to satisfy the tax withholding obligations. The New Mannix Rule 10b5-1 Plan includes a representation from Ms. Mannix to the broker administering the plan that she was not in possession of any material nonpublic information regarding the Company or the securities subject to the New Mannix Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the New Mannix Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the New Mannix Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Ms. Mannix was unaware, or with respect to any material nonpublic information acquired by Ms. Mannix or the Company after the date of the representation. Once executed, transactions under each of the Saintil Rule 10b5-1 Plan, the Blasing Rule 10b5-1 Plan and the New Mannix Rule 10b5-1 Plan will be disclosed publicly through Form 4 and/or Form 144 filings with the Securities and Exchange Commission in accordance with applicable securities laws, rules, and regulations. Except as may be required by law, the Company does not undertake any obligation to update or report any modification, termination, or other activity under current or future Rule 10b5-1 plans that may be adopted by Ms. Saintil, Ms. Blasing, Ms. Mannix or other officers or directors of the Company.
Name	Erin Mannix
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	March 28, 2024
Arrangement Duration	266 days
Aggregate Available	17,797

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Apr. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP.
Fiscal Year	Fiscal Year The Company's fiscal year ends on January 31. For example, references to fiscal year 2025 and 2024 refer to the fiscal year ending January 31, 2025 and the fiscal year ended January 31, 2024, respectively.
Use of Estimates	Use of Estimates The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Such estimates include, but are not limited to, allocation of revenue to the license element in the Company's self-managed subscriptions, estimating the amortization period for capitalized costs to obtain a contract, allowance for doubtful accounts, stock-based compensa tion expense, fair value of contingent consideration, fair valuation of retained interest in an investee on loss of control, valuation allowance for deferred income taxes, reserves for unrecognized income tax benefits, valuation of acquired intangibles assets and impairment of goodwill and equity method investments. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates.
Principles of Consolidation	Principles of Consolidation The condensed consolidated financial statements include 100% of the accounts of wholly owned and majority owned subsidiaries as well as a variable interest entity for which the Company is the primary beneficiary. The ownership interest of other investors is recorded as noncontrolling interest. All intercompany accounts and transactions have been eliminated in consolidation.

Revenues (Tables)

Revenues (Tables)	3 Months Ended
	Apr. 30, 2024
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following table shows the components of revenues and their respective percentages of total revenue for the periods indicated (in thousands, except percentages): Three Months Ended April 30, 2024 2023 Subscription—self-managed and SaaS $ 151,179 89 % $ 111,191 88 % Subscription—self-managed 103,673 61 79,587 63 SaaS 47,506 28 31,604 25 License—self-managed and other $ 18,008 11 % $ 15,687 12 % License—self-managed 14,837 9 13,355 10 Professional services and other 3,171 2 2,332 2 Total revenue $ 169,187 100 % $ 126,878 100 %
Revenue by Geographic Location	The following table summarizes the Company’s total revenue by geographic location based on the region of the Company’s contracting entity, which may be different than the region of the customer (in thousands): Three Months Ended April 30, 2024 2023 United States $ 137,526 $ 102,962 Europe 27,652 20,957 Asia Pacific 4,009 2,959 Total revenue $ 169,187 $ 126,878

Cash, Cash Equivalents and Sh_2

Cash, Cash Equivalents and Short-Term Investments (Tables)	3 Months Ended
	Apr. 30, 2024
Cash and Cash Equivalents [Abstract]
Schedule of Short Term Investments	The following table summarizes the Company’s cash equivalents and short-term investments by category (in thousands): As of April 30, 2024 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Level 1: Cash equivalents (1) Money market funds $ 259,744 $ — $ — $ 259,744 Level 2: Cash equivalents (1) U.S. Treasury securities 57,887 — (3) 57,884 Commercial paper 12,916 — (3) 12,913 Total cash equivalents 330,547 — (6) 330,541 Short-term investments Commercial paper 27,592 2 (17) 27,577 Corporate debt securities 212,399 30 (692) 211,737 U.S. Agency securities 48,848 — (153) 48,695 U.S. Treasury securities 353,904 — (740) 353,164 Total short-term investments 642,743 32 (1,602) 641,173 Level 2 total 713,546 32 (1,608) 711,970 Total cash equivalents and short-term investments $ 973,290 $ 32 $ (1,608) $ 971,714 (1) Included in “cash and cash equivalents” in our condensed consolidated balance sheet as of April 30, 2024, in addition to cash of $89.8 million. As of January 31, 2024 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Level 1: Cash equivalents (1) Money market funds $ 187,175 $ — $ — $ 187,175 Level 2: Cash equivalents (1) U.S. Treasury securities 15,909 — (2) 15,907 Commercial paper 3,962 — (1) 3,961 Total cash equivalents 207,046 — (3) 207,043 Short-term investments Commercial paper 23,229 14 (1) 23,242 Corporate debt securities 231,219 740 (250) 231,709 U.S. Agency securities 56,324 29 (136) 56,217 U.S. Treasury securities 437,369 141 (389) 437,121 Total short-term investments 748,141 924 (776) 748,289 Level 2 total 768,012 924 (779) 768,157 Total cash equivalents and short-term investments $ 955,187 $ 924 $ (779) $ 955,332 (1) Included in “cash and cash equivalents” in our condensed consolidated balance sheet as of January 31, 2024, in addition to cash of $81.0 million.
Schedule of Unrealized Losses Cash Equivalents and Short Term Investment	The following table summarizes unrealized losses on the Company’s cash equivalents and short-term investments aggregated by category and the length of time such aggregated investments have been in a continuous unrealized loss position as of the periods presented (in thousands): Less Than 12 Months 12 Months or Greater Total Carrying Value Gross Unrealized Losses Carrying Value Gross Unrealized Losses Fair Value Gross Unrealized Losses April 30, 2024 U.S. Agency securities $ 36,247 $ (113) $ 9,448 $ (40) $ 45,695 $ (153) Commercial paper 37,421 (20) — — 37,421 (20) Corporate debt securities 168,986 (675) 13,195 (17) 182,181 (692) U.S. Treasury securities 392,924 (704) 18,124 (39) 411,048 (743) Total cash equivalents and short-term investments $ 635,578 $ (1,512) $ 40,767 $ (96) $ 676,345 $ (1,608) Less Than 12 Months 12 Months or Greater Total Carrying Value Gross Unrealized Losses Carrying Value Gross Unrealized Losses Fair Value Gross Unrealized Losses January 31, 2024 U.S. Agency securities $ 35,979 $ (53) $ 11,386 $ (83) $ 47,365 $ (136) Commercial paper 15,462 (2) — — 15,462 (2) Corporate debt securities 85,998 (192) 15,485 (58) 101,483 (250) U.S. Treasury securities 139,567 (192) 41,193 (199) 180,760 (391) Total cash equivalents and short-term investments $ 277,006 $ (439) $ 68,064 $ (340) $ 345,070 $ (779)
Schedule of Short Term Investments by Contractual Maturity	The following table classifies the Company’s short-term investments by contractual maturities (in thousands): April 30, 2024 January 31, 2024 Amortized cost Fair Value Amortized cost Fair Value Due within 1 year $ 500,465 $ 499,318 $ 619,286 $ 618,765 Due between 1 year to 2 years 142,278 141,855 128,855 129,524 Total $ 642,743 $ 641,173 $ 748,141 $ 748,289

Supplemental Financial Statem_2

Supplemental Financial Statement Information (Tables)	3 Months Ended
	Apr. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Accrued Liabilities	Accrued expenses and other current liabilities consisted of the following (in thousands): April 30, 2024 January 31, 2024 Income tax liability related to BAPA (1) $ 265,254 $ 258,675 Accrued expenses 21,015 11,499 ESPP employee contributions 6,912 2,827 Acquisition related liabilities (2) 3,766 3,608 Income taxes payable 3,380 2,212 Customer refunds payable 3,335 3,019 Indirect taxes payable 2,701 3,928 Operating lease liabilities, current 371 410 Total accrued expenses and other current liabilities $ 306,734 $ 286,178 (1) Refer to “Note 12. Income Taxes” for a discussion on the unrecognized tax benefits related to the BAPA. (2) $0.1 million relates to Oxeye acquisition founder holdback (see Note 6. Business Combination
Schedule of Other Income, Net	Other income (expense), net consisted of the following (in thousands): Three Months Ended April 30, 2024 2023 Foreign exchange gains (losses), net $ (637) $ 274 Other income (expense), net 70 (21) Total other income (expense), net $ (567) $ 253

Business Combination (Tables)

Business Combination (Tables)	3 Months Ended
	Apr. 30, 2024
Business Combination and Asset Acquisition [Abstract]
Schedule of Business Acquisitions, by Acquisition	The transaction was accounted for as a business combination. The Acquisition Date fair value of the consideration transferred consisted of the following (in thousands): Closing cash consideration $ 16,737 Cash held in escrow 3,593 Total consideration $ 20,330 The following table reflects the fair values of assets acquired and liabilities assumed (in thousands): Cash and cash equivalents $ 120 Developed technology 16,276 Goodwill 8,055 Prepaid expenses and other current assets 121 Accrued expenses and payroll (3,582) Deferred tax liability (660) Net assets acquired $ 20,330

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets, Net (Tables)	3 Months Ended
	Apr. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The carrying amount of goodwill was as follows (in thousands): Carrying Amount Balance as of January 31, 2024 $ 8,145 Acquisition of Oxeye 8,055 Foreign currency translation adjustments (130) Balance as of April 30, 2024 $ 16,070
Schedule of Finite-Lived Intangible Assets	Intangible assets, net consisted of the following (in thousands): April 30, 2024 (1) Gross Carrying Amount Accumulated Amortization Net Book Value Weighted average remaining amortization period (years) Developed technology from business combination $ 22,192 $ (5,555) $ 16,637 2.5 Developed technology from asset acquisitions 906 (906) — 0.0 Total $ 23,098 $ (6,461) $ 16,637 January 31, 2024 Gross Carrying Amount Accumulated Amortization Net Book Value Weighted average remaining amortization period (years) Developed technology from business combination $ 6,200 $ (4,467) $ 1,733 0.8 Developed technology from asset acquisitions (1) 914 (914) — 0.0 Total $ 7,114 $ (5,381) $ 1,733 (1) The amounts in the tables above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying intangibles.
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	As of April 30, 2024, future a mortization expense related to the intangibles assets is expected to be as follows (in thousands): Fiscal Years 2025 $ 5,221 2026 5,330 2027 5,330 2028 756 Total future amortization $ 16,637

Equity (Tables)

Equity (Tables)	3 Months Ended
	Apr. 30, 2024
Equity [Abstract]
Schedule of Stock Reserved For Future Issuance	The Company had shares of common stock reserved for future issuance as follows (in thousands): April 30, 2024 January 31, 2024 Class A and Class B common stock Options issued and outstanding 7,880 8,503 Shares available for issuance under Equity Incentive Plans 30,067 24,868 RSUs and PSUs issued and outstanding 12,960 10,930 Shares reserved for issuance to charitable organizations 1,351 1,404 ESPP 6,974 5,398 Total 59,232 51,103
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award	The awards available for grant under the above Plans for the pe riods presented were as follows (in thousands): April 30, 2024 January 31, 2024 Available at beginning of period 24,868 21,483 Awards authorized 7,878 7,557 RSUs and PSUs granted (3,159) (6,258) RSUs and PSUs canceled and forfeited 418 1,292 Options canceled and forfeited 62 777 Options repurchased — 17 Available at end of period 30,067 24,868
Share-based Payment Arrangement, Option, Activity	The following table summarizes options activity under the Plans, and related information: Number of Stock Options Outstanding (in thousands) Weighted Average Exercise Price Weighted Average Remaining Years Aggregate Intrinsic value (in millions) Balances at January 31, 2024 8,503 $ 13.03 5.85 $ 499.2 Options granted — — — Options exercised (561) 9.08 — Options canceled (6) 10.11 — Options forfeited (56) 18.79 — Balances at April 30, 2024 7,880 $ 13.27 5.63 $ 312.6 Options vested at April 30, 2024 6,213 $ 11.98 5.37 $ 251.6 Options vested and expected to vest at April 30, 2024 7,880 $ 13.27 5.63 $ 312.6
Schedule of Restricted Stock Units Activity	The following table summarizes the Company’s RSU activity: Number of Shares (in thousands) (1) Weighted- Balances at January 31, 2024 7,701 $ 47.20 Granted 3,159 56.18 Vested (711) 47.77 Canceled/forfeited (418) 50.02 Balances at April 30, 2024 9,731 $ 49.93 (1)
Schedule of Share Based Compensation Expense	The Company recognized stock-based compensation expense as follows (in thousands): Three Months Ended April 30, 2024 2023 Cost of revenue $ 1,855 $ 1,414 Sales and marketing 17,397 13,764 Research and development 12,336 11,702 General and administrative 10,664 5,450 Total stock-based compensation expense (1) $ 42,252 $ 32,330 (1) The table above includes stock-based compensation of JiHu. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Restructuring and Other Relat_2

Restructuring and Other Related Charges (Tables)	3 Months Ended
	Apr. 30, 2024
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Charges	The Company recognized severance and other termination benefit costs as follows (in thousands): Three Months Ended April 30, 2024 2023 Cost of revenue $ — $ 417 Research and development — 2,059 Sales and marketing 730 3,559 General and administrative 276 1,618 Total (1) $ 1,006 $ 7,653 (1) Excludes stock-based compensation of zero and $1.3 million for the three months ended April 30, 2024 and 2023, respectively.
Schedule of Restructuring Reserve by Type of Cost	The changes in liabilities resulting from the restructuring charges and related accruals were as follows (in thousands) : Balance as of January 31, 2024 $ 188 Charges 1,006 Cash payments (1,176) Balance as of April 30, 2024 (1) $ 18 (1) Balance is included in accrued compensation and benefits on the condensed consolidated balance sheet as of April 30, 2024.

Joint Venture and Equity Meth_2

Joint Venture and Equity Method Investment (Tables)	3 Months Ended
	Apr. 30, 2024
Noncontrolling Interest [Abstract]
Schedule of Supplemental Information Related to Operating Leases	The table below presents supplemental information related to operating leases for the three months ended April 30, 2024 (in thousands, except weighted-average information): Weighted-average remaining lease term (in years) 0.88 Weighted-average discount rate 3.6 % Right-of-use assets obtained in exchange for new operating lease liabilities $ 284 Cash paid for amounts included in the measurement of lease liabilities $ 195
Schedule of Variable Interest Entities	Selected financial information of JiHu, post intercompany eliminations, is as follows (in thousands): Three Months Ended April 30, 2024 2023 Revenue $ 1,646 $ 1,464 Cost of revenue 484 491 Gross profit 1,162 973 Operating expenses: Sales and marketing 1,635 2,084 Research and development (211) 1,956 General and administrative 838 (1,444) Total operating expenses 2,262 2,596 Loss from operations (1,100) (1,623) Interest income 227 315 Other income, net 347 269 Net loss before income taxes (526) (1,039) Net loss $ (526) $ (1,039) Net loss attributable to noncontrolling interest $ (243) $ (430) April 30, 2024 January 31, 2024 Cash and cash equivalents $ 41,901 $ 43,896 Property and equipment, net 357 489 Operating lease right-of-use assets 543 405 Other assets 3,884 2,835 Total assets $ 46,685 $ 47,625 Total liabilities $ 6,071 $ 6,080

Net Loss per Share (Tables)

Net Loss per Share (Tables)	3 Months Ended
	Apr. 30, 2024
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth basic and diluted loss per share for each of the periods presented (in thousands, except per share data): Three Months Ended April 30, 2024 2023 Numerator: Net loss attributable to GitLab $ (54,644) $ (52,469) Denominator: Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted 158,157 151,692 Net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted $ (0.35) $ (0.35)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in thousands): As of April 30, 2024 January 31, 2024 Shares subject to outstanding common stock options 7,880 8,503 Unvested restricted stock in connection with business combination 2 3 Unvested early exercised stock options 17 22 Unvested RSUs and PSUs 12,960 10,930 Shares subject to the ESPP 155 63 Total 21,014 19,521

Revenues - Disaggregation of Re

Revenues - Disaggregation of Revenue by Product and Service (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Disaggregation of Revenue [Line Items]
Total revenue	$ 169,187	$ 126,878
Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	100%	100%
Subscription—self-managed and SaaS
Disaggregation of Revenue [Line Items]
Total revenue	$ 151,179	$ 111,191
Subscription—self-managed and SaaS | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	89%	88%
Subscription—self-managed
Disaggregation of Revenue [Line Items]
Total revenue	$ 103,673	$ 79,587
Subscription—self-managed | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	61%	63%
SaaS
Disaggregation of Revenue [Line Items]
Total revenue	$ 47,506	$ 31,604
SaaS | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	28%	25%
License—self-managed and other
Disaggregation of Revenue [Line Items]
Total revenue	$ 18,008	$ 15,687
License—self-managed and other | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	11%	12%
License—self-managed
Disaggregation of Revenue [Line Items]
Total revenue	$ 14,837	$ 13,355
License—self-managed | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	9%	10%
Professional services and other
Disaggregation of Revenue [Line Items]
Total revenue	$ 3,171	$ 2,332
Professional services and other | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	2%	2%

Revenues - Disaggregation of _2

Revenues - Disaggregation of Revenue by Geographic Region (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Disaggregation of Revenue [Line Items]
Total revenue	$ 169,187	$ 126,878
United States
Disaggregation of Revenue [Line Items]
Total revenue	137,526	102,962
Europe
Disaggregation of Revenue [Line Items]
Total revenue	27,652	20,957
Asia Pacific
Disaggregation of Revenue [Line Items]
Total revenue	$ 4,009	$ 2,959

Revenues - Narrative (Details)

Revenues - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Jan. 31, 2024
Disaggregation of Revenue [Line Items]
Deferred revenue recognized	$ 125.3	$ 90.6
Remaining performance obligation	$ 681.2		$ 673.8
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-05-01
Disaggregation of Revenue [Line Items]
Remaining performance obligation, next twelve months (as a percent)	64%
Remaining performance obligation, next twenty four months (as a percent)	87%
Accounts Receivable | Credit Concentration Risk | Distribution Channel One
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	10%		12%
Accounts Receivable | Credit Concentration Risk | Distribution Channel Two
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	14%		13%
United States | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	81%	81%

Cash, Cash Equivalents and Sh_3

Cash, Cash Equivalents and Short-Term Investments - Schedule of Cash and Short Term Investments (Details) - USD ($) $ in Thousands	Apr. 30, 2024		Jan. 31, 2024		Apr. 30, 2023
Debt Securities, Available-for-sale [Line Items]
Cash and cash equivalents	$ 420,322	[1]	$ 287,996	[1]	$ 315,933
Cash equivalents and short-term investments, amortized cost	973,290		955,187
Cash equivalents and short-term investments, gross unrealized gains	32		924
Cash equivalents and short-term investments, gross unrealized losses	(1,608)		(779)
Cash equivalents and short-term investments, fair value	971,714		955,332
Level 2
Debt Securities, Available-for-sale [Line Items]
Cash equivalents and short-term investments, amortized cost	713,546		768,012
Cash equivalents and short-term investments, gross unrealized gains	32		924
Cash equivalents and short-term investments, gross unrealized losses	(1,608)		(779)
Cash equivalents and short-term investments, fair value	711,970		768,157
Cash and Cash Equivalents | Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and cash equivalents	330,547		207,046
Cash equivalents, gross unrealized gains	0		0
Cash equivalents, gross unrealized losses	(6)		(3)
Cash equivalents, fair value	330,541		207,043
Short-Term Investments | Level 2
Debt Securities, Available-for-sale [Line Items]
Short-term investments, amortized cost	642,743		748,141
Short-term investments, gross unrealized gains	32		924
Short-term investments, gross unrealized losses	(1,602)		(776)
Short-term investments, fair value	641,173		748,289
Money market funds | Cash and Cash Equivalents | Level 1
Debt Securities, Available-for-sale [Line Items]
Cash and cash equivalents	259,744		187,175
Cash equivalents, fair value	259,744		187,175
U.S. Treasury securities | Cash and Cash Equivalents | Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and cash equivalents	57,887		15,909
Cash equivalents, gross unrealized gains	0		0
Cash equivalents, gross unrealized losses	(3)		(2)
Cash equivalents, fair value	57,884		15,907
U.S. Treasury securities | Short-Term Investments | Level 2
Debt Securities, Available-for-sale [Line Items]
Short-term investments, amortized cost	353,904		437,369
Short-term investments, gross unrealized gains	0		141
Short-term investments, gross unrealized losses	(740)		(389)
Short-term investments, fair value	353,164		437,121
Commercial paper | Cash and Cash Equivalents | Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and cash equivalents	12,916		3,962
Cash equivalents, gross unrealized gains	0		0
Cash equivalents, gross unrealized losses	(3)		(1)
Cash equivalents, fair value	12,913		3,961
Commercial paper | Short-Term Investments | Level 2
Debt Securities, Available-for-sale [Line Items]
Short-term investments, amortized cost	27,592		23,229
Short-term investments, gross unrealized gains	2		14
Short-term investments, gross unrealized losses	(17)		(1)
Short-term investments, fair value	27,577		23,242
Corporate debt securities | Short-Term Investments | Level 2
Debt Securities, Available-for-sale [Line Items]
Short-term investments, amortized cost	212,399		231,219
Short-term investments, gross unrealized gains	30		740
Short-term investments, gross unrealized losses	(692)		(250)
Short-term investments, fair value	211,737		231,709
U.S. Agency securities | Short-Term Investments | Level 2
Debt Securities, Available-for-sale [Line Items]
Short-term investments, amortized cost	48,848		56,324
Short-term investments, gross unrealized gains	0		29
Short-term investments, gross unrealized losses	(153)		(136)
Short-term investments, fair value	48,695		56,217
Cash | Cash and Cash Equivalents
Debt Securities, Available-for-sale [Line Items]
Short-term investments, amortized cost	$ 89,800		$ 81,000
[1] (1) As of April 30, 2024 and January 31, 2024, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $46.7 million and $47.6 million, respectively, and liabilities of $6.1 million and $6.1 million , respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the genera l credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Cash, Cash Equivalents and Sh_4

Cash, Cash Equivalents and Short-Term Investments - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Jan. 31, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest and investment income	$ 12,000	$ 7,300
Net amortization of premiums or discounts on short-term investments	4,900	3,596
Contingent consideration liability, current	3,766		$ 3,608
Accretion expense	0	$ 0
Opstrace Inc.
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration liability, current	$ 3,700
Fair Value, Inputs, Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent cash consideration			$ 3,600

Cash, Cash Equivalents and Sh_5

Cash, Cash Equivalents and Short-Term Investments - Schedule of Unrealized Losses Cash Equivalents and Short Term Investment (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Less than 12 months, carrying value	$ 635,578	$ 277,006
Less than 12 months, gross unrealized losses	(1,512)	(439)
12 months or greater, carrying value	40,767	68,064
12 months or greater, gross unrealized losses	(96)	(340)
Fair Value	676,345	345,070
Gross Unrealized Losses	(1,608)	(779)
U.S. Agency securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Less than 12 months, carrying value	36,247	35,979
Less than 12 months, gross unrealized losses	(113)	(53)
12 months or greater, carrying value	9,448	11,386
12 months or greater, gross unrealized losses	(40)	(83)
Fair Value	45,695	47,365
Gross Unrealized Losses	(153)	(136)
Commercial paper
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Less than 12 months, carrying value	37,421	15,462
Less than 12 months, gross unrealized losses	(20)	(2)
12 months or greater, carrying value	0	0
12 months or greater, gross unrealized losses	0	0
Fair Value	37,421	15,462
Gross Unrealized Losses	(20)	(2)
Corporate debt securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Less than 12 months, carrying value	168,986	85,998
Less than 12 months, gross unrealized losses	(675)	(192)
12 months or greater, carrying value	13,195	15,485
12 months or greater, gross unrealized losses	(17)	(58)
Fair Value	182,181	101,483
Gross Unrealized Losses	(692)	(250)
U.S. Treasury securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Less than 12 months, carrying value	392,924	139,567
Less than 12 months, gross unrealized losses	(704)	(192)
12 months or greater, carrying value	18,124	41,193
12 months or greater, gross unrealized losses	(39)	(199)
Fair Value	411,048	180,760
Gross Unrealized Losses	$ (743)	$ (391)

Cash, Cash Equivalents and Sh_6

Cash, Cash Equivalents and Short-Term Investments - Schedule of Short Term Investments by Contractual Maturity (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Amortized cost
Due within 1 year	$ 500,465	$ 619,286
Due between 1 year to 2 years	142,278	128,855
Total	642,743	748,141
Fair Value
Due within 1 year	499,318	618,765
Due between 1 year to 2 years	141,855	129,524
Total	$ 641,173	$ 748,289

Supplemental Financial Statem_3

Supplemental Financial Statement Information - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands		Apr. 30, 2024	Jan. 31, 2024
Business Acquisition [Line Items]
Income tax liability related to BAPA		$ 265,254	$ 258,675
Accrued expenses		21,015	11,499
ESPP employee contributions		6,912	2,827
Acquisition related liabilities		3,766	3,608
Income taxes payable		3,380	2,212
Customer refunds payable		3,335	3,019
Indirect taxes payable		2,701	3,928
Operating lease liabilities, current		$ 371	$ 410
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]		Total accrued expenses and other current liabilities	Total accrued expenses and other current liabilities
Total accrued expenses and other current liabilities	[1]	$ 306,734	$ 286,178
Oxeye Security Limited
Business Acquisition [Line Items]
Acquisition related liabilities		100
Opstrace Inc.
Business Acquisition [Line Items]
Acquisition related liabilities		$ 3,700
[1] (1) As of April 30, 2024 and January 31, 2024, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $46.7 million and $47.6 million, respectively, and liabilities of $6.1 million and $6.1 million , respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the genera l credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Supplemental Financial Statem_4

Supplemental Financial Statement Information - Other Income, Net (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Foreign exchange gains (losses), net	$ (637)	$ 274
Other income (expense), net	70	(21)
Total other income (expense), net	$ (567)	$ 253

Business Combination - Schedule

Business Combination - Schedule of Total Consideration Transferred (Details) - Oxeye Security Limited - USD ($) $ in Thousands		3 Months Ended
	Mar. 20, 2024	Apr. 30, 2024
Business Acquisition [Line Items]
Closing cash consideration	$ 16,737
Cash held in escrow	3,593
Total consideration	$ 20,330	$ 20,300

Business Combination - Narrativ

Business Combination - Narrative (Details) $ in Thousands		3 Months Ended
	Mar. 20, 2024 USD ($) co-founder tranche	Apr. 30, 2024 USD ($)
Business Acquisition [Line Items]
Number of co-founders | co-founder	2
Oxeye Security Limited
Business Acquisition [Line Items]
Cash held in escrow	$ 3,593
Post-closing indemnification term	15 months
Acquisition related costs		$ 1,300
Total consideration	$ 20,330	20,300
Oxeye Security Limited | Founder Holdback
Business Acquisition [Line Items]
Contingent payment	$ 3,200
Number of contingent payment tranches | tranche	3
Founder holdback consideration expense		$ 100
Oxeye Security Limited | Founder Holdback | Business Combination, Contingent Consideration, Tranche One
Business Acquisition [Line Items]
Contingent payment, time-based vesting, percentage	33.30%
Oxeye Security Limited | Founder Holdback | Business Combination, Contingent Consideration, Tranche Two
Business Acquisition [Line Items]
Contingent payment, time-based vesting, percentage	33.30%
Oxeye Security Limited | Founder Holdback | Business Combination, Contingent Consideration, Tranche Three
Business Acquisition [Line Items]
Contingent payment, time-based vesting, percentage	33.30%
Oxeye Security Limited | Developed Technology
Business Acquisition [Line Items]
Intangible assets acquired, useful life	3 years

Business Combination - Schedu_2

Business Combination - Schedule of Preliminary Fair Values of Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands		Apr. 30, 2024	Mar. 20, 2024	Jan. 31, 2024
Business Acquisition [Line Items]
Goodwill	[1]	$ 16,070		$ 8,145
Oxeye Security Limited
Business Acquisition [Line Items]
Cash and cash equivalents			$ 120
Goodwill			8,055
Prepaid expenses and other current assets			121
Accrued expenses and payroll			(3,582)
Deferred tax liability			(660)
Net assets acquired			20,330
Oxeye Security Limited | Developed Technology
Business Acquisition [Line Items]
Developed technology			$ 16,276
[1] (1) As of April 30, 2024 and January 31, 2024, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $46.7 million and $47.6 million, respectively, and liabilities of $6.1 million and $6.1 million , respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the genera l credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets, Net - Rollforward of Goodwill (Details) $ in Thousands	3 Months Ended
	Apr. 30, 2024 USD ($)
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 8,145	[1]
Acquisition of Oxeye	8,055
Foreign currency translation adjustments	(130)
Goodwill, ending balance	$ 16,070	[1]
[1] (1) As of April 30, 2024 and January 31, 2024, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $46.7 million and $47.6 million, respectively, and liabilities of $6.1 million and $6.1 million , respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the genera l credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets, Net - Narrative (Details) - USD ($)	3 Months Ended		12 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Jan. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill impairment	$ 0		$ 0
Amortization of intangible assets	$ 1,087,000	$ 579,000

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets, Net - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 23,098	$ 7,114
Accumulated Amortization	(6,461)	(5,381)
Total future amortization	16,637	1,733
Developed technology from business combination
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	22,192	6,200
Accumulated Amortization	(5,555)	(4,467)
Total future amortization	$ 16,637	$ 1,733
Weighted average remaining amortization period (years)	2 years 6 months	9 months 18 days
Developed technology from asset acquisitions
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 906	$ 914
Accumulated Amortization	(906)	(914)
Total future amortization	$ 0	$ 0
Weighted average remaining amortization period (years)	0 years	0 years

Goodwill and Intangible Asset_6

Goodwill and Intangible Assets, Net - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
2025	$ 5,221
2026	5,330
2027	5,330
2028	756
Total future amortization	$ 16,637	$ 1,733

Team Member Benefit Plans (Deta

Team Member Benefit Plans (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Retirement Benefits [Abstract]
Defined contribution plan, contribution amount	$ 1.8	$ 1.7

Equity - Narrative (Details)

Equity - Narrative (Details) $ in Thousands		1 Months Ended		3 Months Ended		12 Months Ended
	Feb. 01, 2024 shares	Jun. 30, 2022 shares	May 31, 2021 USD ($) shares	Apr. 30, 2024 USD ($) distribution shares	Apr. 30, 2023 USD ($) shares	Jan. 31, 2024 shares	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Sep. 30, 2021 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards authorized (in shares) | shares				7,878,000		7,557,000
Total stock-based compensation expense				$ 42,252	$ 32,330
Compensation expense not yet recognized				17,600
Grant date fair value of RSUs granted			$ 8,800
Tax benefit for stock-based compensation expense				$ 0	2,800
Number of distributions, donation | distribution				4
Charitable donation of common stock				$ 2,957	2,675
Shares subject to outstanding common stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense				$ 3,500	4,800
Period for recognition (in years)				1 year 4 months 24 days
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense				$ 35,500	23,200
Compensation expense not yet recognized				$ 468,500
Period for recognition (in years)				3 years 1 month 6 days
RSUs | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense				$ 400	400
Period for recognition (in years)				4 years 7 months 6 days
Compensation expense not yet recognized				$ 3,900
RSUs | Minimum | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period for recognition (in years)				2 years
RSUs | Maximum | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period for recognition (in years)				7 years
PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense				$ 600	400
Period for recognition (in years)				1 year 7 months 6 days
RSUs granted in period (in shares) | shares		400,000
Award vesting percentage		100%
Compensation expense not yet recognized				$ 2,300
PSUs | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage		0%
PSUs | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage		200%
2021 Equity Incentive Plan | RSUs | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)				2 years
2021 Equity Incentive Plan | RSUs | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)				4 years
2021 Employee Stock Purchase Plan | ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense				$ 2,600	$ 4,500
Period for recognition (in years)				1 year 7 months 6 days
Compensation expense not yet recognized				$ 10,100
Class B Common Stock | RSUs | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
RSUs granted in period (in shares) | shares			3,000,000
Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for future issuance (in shares) | shares									1,635,545
Aggregate principal amount, donation							$ 11,800	$ 10,700
Charitable donation of common stock (in shares) | shares				53,226	80,742
Charitable donation of common stock				$ 3,000	$ 2,700
Class A Common Stock | 2021 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards authorized (in shares) | shares	7,877,919
Class A Common Stock | 2021 Employee Stock Purchase Plan | ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards authorized (in shares) | shares	1,575,583

Equity - Schedule of Stock Rese

Equity - Schedule of Stock Reserved For Future Issuance (Details) - shares shares in Thousands	Apr. 30, 2024	Jan. 31, 2024	Jan. 31, 2023
Class of Stock [Line Items]
Options issued and outstanding (in shares)	7,880	8,503
Shares available for issuance under Equity Incentive Plans (in shares)	30,067	24,868	21,483
Class A and Class B common stock
Class of Stock [Line Items]
Options issued and outstanding (in shares)	7,880	8,503
Shares available for issuance under Equity Incentive Plans (in shares)	30,067	24,868
Shares reserved for issuance to charitable organizations (in shares)	1,351	1,404
Common stock reserved for future issuance (in shares)	59,232	51,103
RSUs and PSUs | Class A and Class B common stock
Class of Stock [Line Items]
Share-based compensation awards other than options (in shares)	12,960	10,930
ESPP | Class A and Class B common stock
Class of Stock [Line Items]
Share-based compensation awards other than options (in shares)	6,974	5,398

Equity - Awards Available for G

Equity - Awards Available for Grant (Details) - shares shares in Thousands	3 Months Ended	12 Months Ended
	Apr. 30, 2024	Jan. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award, Awards Available For Grant [Roll Forward]
Balance, beginning of period (in shares)	24,868	21,483
Awards authorized (in shares)	7,878	7,557
Options cancelled and forfeited (in shares)	62	777
Options repurchased (in shares)	0	17
Balance, end of period (in shares)	30,067	24,868
RSUs and PSUs
Share-based Compensation Arrangement by Share-based Payment Award, Awards Available For Grant [Roll Forward]
RSUs and PSUs granted (in shares)	(3,159)	(6,258)
RSUs and PSUs cancelled and forfeited (in shares)	418	1,292

Equity - Summary of Stock Optio

Equity - Summary of Stock Option Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended	12 Months Ended
	Apr. 30, 2024	Jan. 31, 2024
Number of Stock Options Outstanding (in thousands)
Balance, beginning of period (in shares)	8,503
Options granted (in shares)	0
Options exercised (in shares)	(561)
Options cancelled (in shares)	(6)
Options forfeited (in shares)	(56)
Balance, end of period (in shares)	7,880	8,503
Options vested (in shares)	6,213
Options expected to vest (in shares)	7,880
Weighted Average Exercise Price
Balance, beginning of period (in USD per share)	$ 13.03
Options granted (in USD per share)	0
Options exercised (in USD per share)	9.08
Options cancelled (in USD per share)	10.11
Options forfeited (in USD per share)	18.79
Balance, end of period (in USD per share)	13.27	$ 13.03
Options vested (in USD per share)	11.98
Options expected to vest (in USD per share)	$ 13.27
Weighted Average Remaining Years
Outstanding (in years)	5 years 7 months 17 days	5 years 10 months 6 days
Options vested (in years)	5 years 4 months 13 days
Options expected to vest (in years)	5 years 7 months 17 days
Aggregate Intrinsic value (in millions)
Outstanding value	$ 312.6	$ 499.2
Options vested	251.6
Options expected to vest	$ 312.6

Equity - Schedule of Restricted

Equity - Schedule of Restricted Stock Units Activity (Details) - RSUs shares in Thousands	3 Months Ended
	Apr. 30, 2024 $ / shares shares
Number of Shares
Balance, beginning of period (in shares)	7,701
Granted (in shares)	3,159
Vested (in shares)	(711)
Canceled/forfeited (in shares)	(418)
Balance, ending of period (in shares)	9,731
Weighted- Average grant date fair value
Balance, beginning of period (in USD per share) | $ / shares	$ 47.20
Granted (in USD per share) | $ / shares	56.18
Vested (in USD per share) | $ / shares	47.77
Canceled/forfeited (in USD per share) | $ / shares	50.02
Balance, ending of period (in USD per share) | $ / shares	$ 49.93
Chief Executive Officer
Number of Shares
Granted (in shares)	3,000

Equity - Stock-Based Compensati

Equity - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 42,252	$ 32,330
Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	1,855	1,414
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	17,397	13,764
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	12,336	11,702
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 10,664	$ 5,450

Restructuring and Other Relat_3

Restructuring and Other Related Charges - Narrative (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended
	Feb. 28, 2023	Apr. 30, 2024	Apr. 30, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$ 1,000	$ 9,000
Positions eliminated, percent	7%
Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring charges		1,006	7,653
One-time Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$ 0	$ 1,300

Restructuring and Other Relat_4

Restructuring and Other Related Charges - Schedule of Restructuring Costs (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 1,000	$ 9,000
Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring charges	1,006	7,653
One-time Termination Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	1,300
Cost of revenue | Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	417
Research and development | Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	2,059
Sales and marketing | Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring charges	730	3,559
General and administrative | Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 276	$ 1,618

Restructuring and Other Relat_5

Restructuring and Other Related Charges - Restructuring Accrual (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Restructuring Reserve [Roll Forward]
Charges	$ 1,000	$ 9,000
Employee Severance
Restructuring Reserve [Roll Forward]
Beginning balance	188
Charges	1,006	$ 7,653
Cash payments	(1,176)
Ending balance	$ 18

Joint Venture and Equity Meth_3

Joint Venture and Equity Method Investment - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Jan. 31, 2024
Noncontrolling Interest [Line Items]
Stock-based compensation	$ 42,252	$ 32,330
Operating lease, total lease payments	500
Operating lease liabilities	500
Operating lease expense	200	200
Impairment of equity method investment			$ (8,900)
Equity method investment			$ 0
Loss from equity method investment, net of tax	0	(748)
Arch (Meltano Inc.)
Noncontrolling Interest [Line Items]
Loss from equity method investment, net of tax	$ 0	700
GitLab Information Technology (Hubei) Co., LTD ("JiHu")
Noncontrolling Interest [Line Items]
Ownership percentage	54%
GitLab Information Technology (Hubei) Co., LTD ("JiHu")
Noncontrolling Interest [Line Items]
Stock-based compensation	$ (300)	$ (2,500)
Compensation expense not yet recognized	$ 1,200
Period for recognition (in years)	3 years 7 months 6 days

Joint Venture and Equity Meth_4

Joint Venture and Equity Method Investment - Supplemental Information Related to Operating Leases (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Leases [Abstract]
Weighted-average remaining lease term (in years)	10 months 17 days
Weighted-average discount rate	3.60%
Right-of-use assets obtained in exchange for new operating lease liabilities	$ 284	$ 0
Cash paid for amounts included in the measurement of lease liabilities	$ 195

Joint Venture and Equity Meth_5

Joint Venture and Equity Method Investment - Schedule of Intercompany Eliminations (Details) - USD ($)		3 Months Ended
		Apr. 30, 2024		Apr. 30, 2023	Jan. 31, 2024
Noncontrolling Interest [Line Items]
Revenue		$ 169,187,000		$ 126,878,000
Cost of revenue		18,776,000		13,939,000
Gross profit		150,411,000		112,939,000
Sales and marketing		92,424,000		86,537,000
Total operating expenses		204,051,000		171,172,000
Loss from operations		(53,640,000)		(58,233,000)
Interest income		12,030,000		7,315,000
Total other income (expense), net		(567,000)		253,000
Net loss		(54,887,000)		(52,899,000)
Net loss attributable to noncontrolling interest		(243,000)		(430,000)
Cash and cash equivalents		420,322,000	[1]	315,933,000	$ 287,996,000	[1]
Property and equipment, net	[1]	2,820,000			2,954,000
Operating lease right-of-use assets		543,000	[1]		405,000
TOTAL ASSETS	[1]	1,321,627,000			1,317,861,000
Total liabilities	[1]	707,269,000			699,927,000
Variable Interest Entity, Primary Beneficiary
Noncontrolling Interest [Line Items]
Revenue		1,646,000		1,464,000
Cost of revenue		484,000		491,000
Gross profit		1,162,000		973,000
Sales and marketing		1,635,000		2,084,000
Research and development		(211,000)		1,956,000
General and administrative		838,000		(1,444,000)
Total operating expenses		2,262,000		2,596,000
Loss from operations		(1,100,000)		(1,623,000)
Interest income		227,000		315,000
Total other income (expense), net		347,000		269,000
Net loss before income taxes		(526,000)		(1,039,000)
Net loss		(526,000)		(1,039,000)
Net loss attributable to noncontrolling interest		(243,000)		$ (430,000)
Cash and cash equivalents		41,901,000			43,896,000
Property and equipment, net		357,000			489,000
Operating lease right-of-use assets		543,000			405,000
Other assets		3,884,000			2,835,000
TOTAL ASSETS		46,685,000			47,625,000
Total liabilities		$ 6,071,000			$ 6,080,000
[1] (1) As of April 30, 2024 and January 31, 2024, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $46.7 million and $47.6 million, respectively, and liabilities of $6.1 million and $6.1 million , respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the genera l credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Jan. 31, 2024
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 12,710	$ 1,486
Loss before income taxes and loss from equity method investment	42,177	$ 50,665
Unrecognized tax benefits	398,300
Unrecognized tax benefits that would effect tax rate	210,300
Unrecognized tax benefits, current	209,700
Interest and penalties recognized	56,700		$ 52,100
Unrecognized tax benefits, income tax penalties expense	$ 8,700		$ 254,900

Net Loss per Share - Schedule o

Net Loss per Share - Schedule of Earning Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Numerator:
Net loss attributable to GitLab, basic	$ (54,644)	$ (52,469)
Net loss attributable to GitLab, diluted	$ (54,644)	$ (52,469)
Denominator:
Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, basic (in shares)	158,157	151,692
Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, diluted (in shares)	158,157	151,692
Net loss per share attributable to GitLab Class A and Class B common stockholders, basic (in USD per share)	$ (0.35)	$ (0.35)
Net loss per share attributable to GitLab Class A and Class B common stockholders, diluted (in USD per share)	$ (0.35)	$ (0.35)

Net Loss per Share - Schedule_2

Net Loss per Share - Schedule of Potentially Dilutive Securities (Details) - shares shares in Thousands	3 Months Ended	12 Months Ended
	Apr. 30, 2024	Jan. 31, 2024
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	21,014	19,521
Shares subject to outstanding common stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	7,880	8,503
Unvested restricted stock in connection with business combination
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	2	3
Unvested early exercised stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	17	22
Unvested RSUs and PSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	12,960	10,930
Shares subject to the ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	155	63

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Millions	Apr. 30, 2024	Jan. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Purchase obligation	$ 136.8
Estimate of possible loss	$ 2.1	$ 2.2

Subsequent Event (Details)

Subsequent Event (Details) $ in Millions	May 23, 2024 USD ($)
Rezilion Asset Acquisition | Subsequent Event
Subsequent Event [Line Items]
Asset acquisition, consideration transferred	$ 7.3